Rafferty Asset Management, LLC PROGENICS PHARMACEUTICALS IN Transaction History

Rafferty Asset Management, LLC

  • $28.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
N/A
-11,724 Closed
0 $0
Q1 2020

May 15, 2020
SELL
N/A
-87,884 Reduced 88.23%
11,724 $45,000
Q4 2019

Feb 10, 2020
SELL
N/A
-29,792 Reduced 23.02%
99,608 $507,000
Q3 2019

Nov 14, 2019
SELL
N/A
-54,289 Reduced 29.55%
129,400 $654,000
Q2 2019

Aug 09, 2019
SELL
N/A
-12,328 Reduced 6.29%
183,689 $1.13 Million
Q1 2019

May 15, 2019
BUY
N/A
196,017 New
196,017 $910,000
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email